This issue of Radiologic Clinics of North America focuses on Breast Imaging and is edited by Dr. Phoebe E. Freer. Articles will include: Management of High-risk Lesions in Breast Cancer; Contrast Mammography and Tomosynthesis; Breast Radiology Advocacy: Responding to the Call-to-Action; Artificial Intelligence and Breast Imaging; Is It the Era for Personalized Breast Cancer Screening?; Understanding the Mammography Audit; MRI Screening of Breast Cancer; Abbreviated MRI for Breast Cancer; Overdiagnosis and Risks of Breast Cancer Screening; MRI Audit of Screening and Diagnostic Breast Imaging; Supplemental Screening for Breast Cancer in Patients at Intermediate and High Risk; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. CME Accreditation Page - p. ix 7. Forthcoming Issues - p. xi 8. Preface - p. xiii 9. The Impact of the COVID-19 Pandemic on Breast Imaging - p. 1 10. Breast Radiology Advocacy: Responding to the Call-to-Action - p. 13 11. Overdiagnosis and Risks of Breast Cancer Screening - p. 19 12. Management of High-Risk Breast Lesions - p. 29 13. Understanding the Mammography Audit - p. 41 14. Breast Magnetic Resonance Imaging Audit: Pitfalls, Challenges, and Future Considerations - p. 57 15. Supplemental Screening for Patients at Intermediate and High Risk for Breast Cancer - p. 67 16. Magnetic Resonance Imaging in Screening of Breast Cancer - p. 85 17. Abbreviated MR Imaging for Breast Cancer - p. 99 18. Contrast-Enhanced Mammography Implementation, Performance, and Use for Supplemental Breast Cancer Screening - p. 113 19. Is It the Era for Personalized Screening? - p. 129 20. Applications of Artificial Intelligence in Breast Imaging - p. 139
This issue of Radiologic Clinics of North America focuses on Breast Imaging and is edited by Dr. Phoebe E. Freer. Articles will include: Management of High-risk Lesions in Breast Cancer; Contrast Mammography and Tomosynthesis; Breast Radiology Advocacy: Responding to the Call-to-Action; Artificial Intelligence and Breast Imaging; Is It the Era for Personalized Breast Cancer Screening?; Understanding the Mammography Audit; MRI Screening of Breast Cancer; Abbreviated MRI for Breast Cancer; Overdiagnosis and Risks of Breast Cancer Screening; MRI Audit of Screening and Diagnostic Breast Imaging; Supplemental Screening for Breast Cancer in Patients at Intermediate and High Risk; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. CME Accreditation Page - p. ix 7. Forthcoming Issues - p. xi 8. Preface - p. xiii 9. The Impact of the COVID-19 Pandemic on Breast Imaging - p. 1 10. Breast Radiology Advocacy: Responding to the Call-to-Action - p. 13 11. Overdiagnosis and Risks of Breast Cancer Screening - p. 19 12. Management of High-Risk Breast Lesions - p. 29 13. Understanding the Mammography Audit - p. 41 14. Breast Magnetic Resonance Imaging Audit: Pitfalls, Challenges, and Future Considerations - p. 57 15. Supplemental Screening for Patients at Intermediate and High Risk for Breast Cancer - p. 67 16. Magnetic Resonance Imaging in Screening of Breast Cancer - p. 85 17. Abbreviated MR Imaging for Breast Cancer - p. 99 18. Contrast-Enhanced Mammography Implementation, Performance, and Use for Supplemental Breast Cancer Screening - p. 113 19. Is It the Era for Personalized Screening? - p. 129 20. Applications of Artificial Intelligence in Breast Imaging - p. 139
